GEO Investing

Pro Research Updates

Our research updates, often shorter in length, are conveyed through initial and ongoing coverage of our catalog of stocks. With thousands of original research pieces and updates under our belt, we have an archival system of keeping the history of our coverage intact and easy to find. For examples of how you will receive this research please see a few case studies showing the chronology of a few notable stocks.

Below you can find the most recent stocks that we have issued original research on, or updates to original research.

Log in below with your Premium Account to see the most recent coverage.

The FULL list of Spotlight Research can be found HERE, which has years of coverage and updates – all archived for your reference. Feel free to use the Advanced Filter at that page to quickly find coverage on stock of interest.

Latest Stock Coverage

Lakeland Industries, Inc. (LAKE)

Lakeland Industries, Inc. (NASDAQ:LAKE) ($2 $167.1M market cap) announced the pricing of a $40 million public offering. The company is offering 1.82 million shares at $22.00 per share. “Lakeland intends to use the net proceeds from the proposed offering for the repayment of certain indebtedness, and for operations and the growth of its business, including working capital and other genera...

Champions Oncology, Inc. (CSBR)

A Note on CSBR In Light Of Nvidia CEO Comments, And Trump New Stargate Initiative In late December 2024, GeoInvesting contributor MS Microcaps published a report on Champions Oncology, Inc. (NASDAQ:CSBR), “Champions Oncology, Inc. (CSBR) InfoArb Cliff Note: New Contract Tucked Away in SEC Filing Goes Unnoticed”. In a nutshell, companies hire CSBR to do cancer research using CSBR’...

Flexible Solutions International (FSI)

A recent development has positioned a little-known company for what could be a significant transformation. With a new customer that has the potential to double the size of the business and improve margins, the company is entering a new market with broad growth opportunities. However, we found commentary about additional new customer relationships that should be announced soon. This commentary was...

Interpace Biosciences, Inc. (IDXG)

Interpace Biosciences, Inc. (OTC:IDXG) ($0.96; $4.2M market cap) - In our December open forum, to address a member’s question, Maj and Jan touched on IDXG’s recent strong results, capital structure and possible loss of medicare/medicaid coverage. The stock was trading at around $3 per share. On January 9th, 2025, the company announced that its PancraGEN diagnostic test will no longer...

CALIFORNIA NANOTECHNOLOGIES COR (CANOF)

California Nanotechnologies Corp. (TSXV:CNO) (CANOF) ($0.63; $29.3M market cap), reported Q3 2025 results: Sales of $1.8 million vs $1.1 million in the prior year Adjusted EBITDA US$826,453 for the quarter compared with US$426,686 in the prior year period. Adjusted EPS of $0.01 vs $0.01 in the prior year "Our momentum has continued into this fiscal quarter as we executed our growth pla...

Viewing page 2 of 4|Previous Page|Next Page